Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harold Marcotte

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Journal of Clinical Immunology|January 29, 2022
Inherited IFNAR1 Deficiency in a Child with Both Critical COVID-19 Pneumonia and Multisystem Inflammatory SyndromeHassan Abolhassani, Nils Landegren, Paul Bastard, et al.
Iscience|April 17, 2023
19n01, a broadly neutralizing antibody against omicron BA.1, BA.2, BA.4/5, and other SARS-CoV-2 variants of concernMelissa García-Vega, Edgar A Melgoza-González, Sofía Hernández-Valenzuela, et al.
Nature Communications|May 13, 2022
Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variantFanglei Zuo, Hassan Abolhassani, Likun Du, et al.
Med (New York, N.Y.)|February 16, 2021
Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infectionNatalia Sherina, Antonio Piralla, Likun Du, et al.
BMC Medicine|March 3, 2022
Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variantMaren Schubert, Federico Bertoglio, Stephan Steinke, et al.
Iscience|January 12, 2022
Immunity to SARS-CoV-2 up to 15 months after infectionHarold Marcotte, Antonio Piralla, Fanglei Zuo, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 9, 2024
Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents infection of Omicron lineagesHarold Marcotte, Yunlong Cao, Fanglei Zuo, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2022
Human neutralizing antibodies to cold linear epitopes and to subdomain 1 of SARS-CoV-2Filippo Bianchini, Virginia Crivelli, Morgan E Abernathy, et al.
Science Immunology|January 26, 2023
Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoproteinFilippo Bianchini, Virginia Crivelli, Morgan E Abernathy, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Jeanna A Bugaytsova, Kristof Moonens, Artem Piddubnyi, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Journal of Clinical Immunology|January 29, 2022
Inherited IFNAR1 Deficiency in a Child with Both Critical COVID-19 Pneumonia and Multisystem Inflammatory SyndromeHassan Abolhassani, Nils Landegren, Paul Bastard, et al.
Iscience|April 17, 2023
19n01, a broadly neutralizing antibody against omicron BA.1, BA.2, BA.4/5, and other SARS-CoV-2 variants of concernMelissa García-Vega, Edgar A Melgoza-González, Sofía Hernández-Valenzuela, et al.
Nature Communications|May 13, 2022
Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variantFanglei Zuo, Hassan Abolhassani, Likun Du, et al.
Med (New York, N.Y.)|February 16, 2021
Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infectionNatalia Sherina, Antonio Piralla, Likun Du, et al.
BMC Medicine|March 3, 2022
Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variantMaren Schubert, Federico Bertoglio, Stephan Steinke, et al.
Iscience|January 12, 2022
Immunity to SARS-CoV-2 up to 15 months after infectionHarold Marcotte, Antonio Piralla, Fanglei Zuo, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 9, 2024
Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents infection of Omicron lineagesHarold Marcotte, Yunlong Cao, Fanglei Zuo, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2022
Human neutralizing antibodies to cold linear epitopes and to subdomain 1 of SARS-CoV-2Filippo Bianchini, Virginia Crivelli, Morgan E Abernathy, et al.
Science Immunology|January 26, 2023
Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoproteinFilippo Bianchini, Virginia Crivelli, Morgan E Abernathy, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Jeanna A Bugaytsova, Kristof Moonens, Artem Piddubnyi, et al.
Pageof 5